MetaCap

Oaktree Acquisition Corp. III Life Sciences Class A Company Profile

NASDAQ: OACCFinanceBlank ChecksUSD

10.760.00 (0.00%)

At close: Oct 8, 4:00 PM ET · Delayed 15 min

Oaktree Acquisition III Life Sciences at a glance

Oaktree Acquisition Corp. III Life Sciences Class A (NASDAQ: OACC) is a Blank Checks company in the Finance sector headquartered in Los Angeles, CA. Oaktree Acquisition III Life Sciences is led by Mr. Zaid Pardesi. The company's shares have traded publicly since 2024.

At a market capitalization of $264.5 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002029769, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Oaktree Acquisition III Life Sciences do?

Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was founded in 1995 and is headquartered in Los Angeles, California.

Business description based on the company's public filings.

Company information

Legal name
Oaktree Acquisition Corp. III Life Sciences Class A
Ticker
NASDAQ: OACC
Sector
Finance
Industry
Blank Checks
CEO
Mr. Zaid Pardesi
Headquarters
333 South Grand Avenue, Los Angeles, CA, United States
Phone
213 830 6300
IPO year
2024
Market cap
$264.51M
SEC CIK
0002029769

Companies similar to Oaktree Acquisition III Life Sciences

Related